Why hospitals mergers fail to improve care

Amy Baxter | | Health Exec | Quality
Hospital staff walking through a medical facility, intentionally blurred to look artistic

Healthcare mergers and acquisition has been on a hot streak for a number of years, but not all hospital mergers end up achieving their stated goals. For instance, hospital mergers may actually increase prices rather than decrease them.

This means that what hospitals say and what they do is actually quite different, Robert Pearl, MD, a Stanford University professor, wrote in Forbes. In addition, there are three reasons why hospital mergers will “fail to improve American healthcare in the future,” according to Pearl.

Here are the three reasons:

  1. Cost containment isn’t a goal––promises to reduce waste and increase savings to payers simply aren’t true.
  2. Quality doesn’t improve without changes in care delivery––hospital consolidations don’t actually improve care delivery.
  3. Hospital revenues hurt by technologies to improve patient care––while new technologies like 3D-printed implants and robotic surgeries attract patients, they don’t actually improve care.

See the full story below:

3 Reasons Hospital Mergers Fail

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

The top 25 heart hospitals in the United States
Death from heart disease more common in rural areas—what can cardiologists do?
Enhancing STAT radiology exam order efficiency to reduce turnaround time
Atrial Fibrillation Centers of Excellence: The best path forward for high-quality care and better outcomes
Family of heart patient who died awarded $45M after suing health system for negligence
FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system

Around the web

Cardiovascular Business
AMA agrees to help after initial request for an independent cardiovascular board was denied

After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some support. "We feel like it's time for us to blaze our own path," one specialist explained. 

Cardiovascular Business
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.